Nurix Therapeutics NRIX
NASDAQ NRIX
$26.02 -0.08 (-0.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Receivables - Other (2020 - 2026)

Updated

Nurix Therapeutics (NRIX) recorded Receivables - Other of $5 million in fiscal Q3 2021 (quarter ended Aug 31, 2021).

Analysis

Nurix Therapeutics (NRIX) Receivables - Other (2020 - 2026) Analysis & Trends

At the end of FY2020 (ended Nov 30, 2020), Nurix Therapeutics reported Receivables - Other of $7.5 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Nurix Therapeutics 2.90 Bn 275.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 8.00 Mn
Aug 31, 2021 5.00 Mn
Nov 30, 2020 7.50 Mn
API Access

Nurix Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=NRIX&period=max&api_key=YOUR_API_KEY